中医临床研究
中醫臨床研究
중의림상연구
Clinical Journal of Chinese Medicine
2015年
33期
72-73
,共2页
扶正祛瘀逐水法%肝硬化腹水%临床研究
扶正祛瘀逐水法%肝硬化腹水%臨床研究
부정거어축수법%간경화복수%림상연구
Fuzheng Quyu fluid-purging therapy%Ascites due to cirrhosis%Clinical research
目的:观察扶正祛瘀逐水法治疗肝硬化腹水的临床疗效,为治疗方案的制定提供依据.方法:将2013年5月-2015年5月本院收治的60例肝硬化腹水患者纳入研究对象.按照随机对照的原则将所有患者分成观察组和对照组均30例.对照组患者仅运用西医治疗,观察组在对照组基础上运用中医扶正祛瘀逐水法进行治疗,疗程为4周.治疗结束后,比较两组患者的临床疗效、体重、腹围、24 h尿量及B超腹水量,观察其异同.结果:经过治疗后,观察组的临床疗效显著好于对照组;体重、腹围、24 h尿量及B超腹水量等临床指标也显著好于对照组患者,差异有统计学意义(P<0.05).结论:采用扶正祛瘀逐水法治疗肝硬化腹水,可以明显提升临床疗效,改善临床指标,可以于临床上推广应用.
目的:觀察扶正祛瘀逐水法治療肝硬化腹水的臨床療效,為治療方案的製定提供依據.方法:將2013年5月-2015年5月本院收治的60例肝硬化腹水患者納入研究對象.按照隨機對照的原則將所有患者分成觀察組和對照組均30例.對照組患者僅運用西醫治療,觀察組在對照組基礎上運用中醫扶正祛瘀逐水法進行治療,療程為4週.治療結束後,比較兩組患者的臨床療效、體重、腹圍、24 h尿量及B超腹水量,觀察其異同.結果:經過治療後,觀察組的臨床療效顯著好于對照組;體重、腹圍、24 h尿量及B超腹水量等臨床指標也顯著好于對照組患者,差異有統計學意義(P<0.05).結論:採用扶正祛瘀逐水法治療肝硬化腹水,可以明顯提升臨床療效,改善臨床指標,可以于臨床上推廣應用.
목적:관찰부정거어축수법치료간경화복수적림상료효,위치료방안적제정제공의거.방법:장2013년5월-2015년5월본원수치적60례간경화복수환자납입연구대상.안조수궤대조적원칙장소유환자분성관찰조화대조조균30례.대조조환자부운용서의치료,관찰조재대조조기출상운용중의부정거어축수법진행치료,료정위4주.치료결속후,비교량조환자적림상료효、체중、복위、24 h뇨량급B초복수량,관찰기이동.결과:경과치료후,관찰조적림상료효현저호우대조조;체중、복위、24 h뇨량급B초복수량등림상지표야현저호우대조조환자,차이유통계학의의(P<0.05).결론:채용부정거어축수법치료간경화복수,가이명현제승림상료효,개선림상지표,가이우림상상추엄응용.
Objective: To observe the clinical efficacy of Fuzheng Quyu fluid-purging therapy in treating ascites due to cirrhosis, and to provide the evidence for the development of treatment programs. Methods: 60 cases of liver cirrhosis, admitted to our hospital from May 2013 to May 2015, were randomized into the observation group and the control group evenly. The control group patients received only western medicine and the observation group received an extra Fuzheng Quyu fluid-purging therapy. The treatment last four weeks, after which the clinical efficacy of the two groups were compared in terms of weight, abdominal circumference, 24h urine as well as B-ascites. Results: After treatment, the clinical efficacy of observation group was significantly better than that of the control group; the observation group patients' clinical indicators of weight, abdominal circumference, 24h urine as well as B-ascites, were also significantly better than that of the control group of patients, the difference was statistically significant (P<0.05). Conclusion: Fuzheng Quyu fluid-purging therapy can significantly enhance the clinical efficacy and improve clinical parameters in treating ascites due to cirrhosis, it could be clinically applied.